Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Lassa Fever (Lassa Hemorrhagic Fever) - Overview Lassa Fever (Lassa Hemorrhagic Fever) - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Lassa Fever (Lassa Hemorrhagic Fever) - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Lassa Fever (Lassa Hemorrhagic Fever) - Companies Involved in Therapeutics Development Celgene Corp Etubics Corp GeoVax Labs Inc Inovio Pharmaceuticals Inc Kineta Inc Profectus BioSciences Inc Lassa Fever (Lassa Hemorrhagic Fever) - Drug Profiles CC-11050 - Drug Profile Product Description Mechanism Of Action R&D Progress GEOLM-01 - Drug Profile Product Description Mechanism Of Action R&D Progress KIN-1400 - Drug Profile Product Description Mechanism Of Action R&D Progress lassa fever vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress lassa fever vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress lassa fever vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress lassa fever vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress lassa fever vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress LHF-535 - Drug Profile Product Description Mechanism Of Action R&D Progress ML-29 - Drug Profile Product Description Mechanism Of Action R&D Progress Monoclonal Antibodies for Lassa Fever - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules for Lassa Fever - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules to Inhibit NPC1 for Ebola and Lassa Fever Virus - Drug Profile Product Description Mechanism Of Action R&D Progress ST-193 - Drug Profile Product Description Mechanism Of Action R&D Progress Lassa Fever (Lassa Hemorrhagic Fever) - Dormant Projects Lassa Fever (Lassa Hemorrhagic Fever) - Product Development Milestones Featured News & Press Releases Oct 24, 2017: Inovio and U.S. Army Co-developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection in Pre-Clinical Study Jul 24, 2017: GeoVax Joins with Scripps Research Institute and Institute of Human Virology at University of Maryland School of Medicine to Develop Lassa Fever Vaccine Jul 11, 2017: Tulane University awarded $12 million to create Lassa vaccine and treatment Jul 10, 2017: GeoVax Reports Promising Results for Lassa Fever Vaccine May 05, 2016: Kineta Receives Wellcome Trust Award to Advance Novel Therapeutic for Lassa Fever into Clinical Trials Apr 22, 2016: Kineta Presents Promising New Data on Novel Lassa Fever Antiviral and Broad Spectrum Innate Immune Antivirals Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer

List of Tables Number of Products under Development for Lassa Fever (Lassa Hemorrhagic Fever), H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Universities/Institutes, H1 2018 Products under Development by Companies, H1 2018 Products under Development by Universities/Institutes, H1 2018 Number of Products by Stage and Target, H1 2018 Number of Products by Stage and Mechanism of Action, H1 2018 Number of Products by Stage and Route of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018 Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Celgene Corp, H1 2018 Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Etubics Corp, H1 2018 Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by GeoVax Labs Inc, H1 2018 Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Inovio Pharmaceuticals Inc, H1 2018 Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Kineta Inc, H1 2018 Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Profectus BioSciences Inc, H1 2018 Lassa Fever (Lassa Hemorrhagic Fever) - Dormant Projects, H1 2018List of Figures Number of Products under Development for Lassa Fever (Lassa Hemorrhagic Fever), H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products by Targets, H1 2018 Number of Products by Stage and Targets, H1 2018 Number of Products by Mechanism of Actions, H1 2018 Number of Products by Stage and Mechanism of Actions, H1 2018 Number of Products by Routes of Administration, H1 2018 Number of Products by Stage and Routes of Administration, H1 2018 Number of Products by Molecule Types, H1 2018 Number of Products by Stage and Molecule Types, H1 2018